Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting

Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting

Abstract Background With the development of next generation sequencing technologies in France, exome sequencing (ES) has recently emerged as an opportunity to improve the diagnosis rate of patients presenting an intellectual disability (ID). To help French policy makers determine an adequate tariff...

Full description

Bibliographic Details
Main Authors: AL Soilly, C Robert-Viard, C Besse, AL Bruel, B Gerard, A Boland, A Piton, Y Duffourd, J Muller, C Poë, T Jouan, S El Doueiri, L Faivre, D Bacq-Daian, B Isidor, D Genevieve, S Odent, N Philip, M Doco-Fenzy, D Lacombe, ML Asensio, JF Deleuze, C Binquet, DISSEQ Investigators Group, C Thauvin-Robinet, C Lejeune
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Health Services Research
Subjects:
Intellectual disability
Exome sequencing
Micro-costing
Cost analysis
Online Access:https://doi.org/10.1186/s12913-023-09373-z

Internet

https://doi.org/10.1186/s12913-023-09373-z

Similar Items